product dossiers in the portfolio (based on 131 INNs**)
new medicinal products are launched on the market annually
The main focus is on the 6 groups:
- 1R Respiratory system – 21.3%
- 2A Alimentary tract and metabolism – 21.4%
- 3N Nervous system – 12.1%
- 4C Cardiovascular system – 8.9%
- 5J Antiinfectives for systemic use – 6.8%
- 6M Musculo-skeletal system – 6.5%
- 7Other – 23.1%
Over UAH 2.3** bn
over the past 7 years
where UAH 500** million –
are the investments
in API manufacturing in Shostka.
more than 140** million grn were allocated for investments in laboratory and production modernization
- employees (including
amongst 18 specialists with academic degree
(15 – Candidates of Science, 3 – Doctors of Science)
- 131products are under development at different stages
- 72amongst 72 products are with new INNs
* in end-user prices, according to Proxima Research data for year 2016.
** according to Farmak internal information.
** INN means International Nonproprietary Name.